Home / Stocks / KABRADG
Back to all stocks
BSE · KABRADG

Kabra Drugs Ltd (KABRADG) Share Price

Sector: Healthcare · ISIN: INE323K01017

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,544
of 5,047 stocks
▲ 871W▲ 591M
Peak #3,482 · 02 Oct 2026

A microcap name in Healthcare, Kabra Drugs Ltd trades at an undemanding earnings multiple, has a widely-held ownership base, with promoters at just 0%, and is growing revenue modestly. Ownership as of Jun 2026.

Market Cap
45.07 Cr
P/E Ratio
9.10
P/B Ratio
1.52
ROE
16.75%
ROCE
19.34%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ2 2026-27Q1 2026-27Q4 2025-26Q3 2025-26
Revenue31.95 Cr46.22 Cr35.41 Cr30.42 Cr
Net Profit1.92 Cr2.12 Cr1.06 Cr2.57 Cr
EPS0.810.900.451.08
Operating Profit2.67 Cr2.85 Cr1.44 Cr2.60 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
0.00%
Public
100.00%

PUBLIC BREAKDOWN

Individuals
93.10%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-DateTypeDetails
13 Sep 2006OtherGeneral

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs